← Leaderboards
H. Daniel Lacorazza
Sloan-Kettering Institute For Cancer Res
$5,869,157
Attributed
$6,749,565
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,749,565 · 6
By mechanism
R01$5,600,905 · 4
K01$735,975 · 1
R21$412,685 · 1
Top collaborators
- Karl A Scheidt2 shared
- Gary E Schiltz2 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMolecularPropertyGenesMouse ModelTranscription FactorExhibitsHematopoietic Stem CellsBaseRecurrent DiseasePharmaceutical PreparationsPlayResponseDisease RemissionHematologic NeoplasmsLeukemiaLymphoidTargeted TreatmentMaintenancePathway InteractionsT-LymphocyteInhibitor/AntagonistHematopoiesisIn Vivo
Grant awards (20)
A Molecular Approach to Dissecting MEK-Mediated Phosphorylation in Pediatric Leukemia$652,805
R01 · FY2025 · CA
Targeting DYRK2 to eradicate leukemia stem cells in chronic myeloid leukemia.$399,746
R01 · FY2025 · CA · contact PI
A Molecular Approach to Dissecting MEK-Mediated Phosphorylation in Pediatric Leukemia$667,807
R01 · FY2024 · CA
Targeting DYRK2 to eradicate leukemia stem cells in chronic myeloid leukemia.$426,306
R01 · FY2024 · CA · contact PI
Discovery of MAP2K7 Inhibitors Through DNA-Encoded Chemical Screens to Treat T-Cell Acute Lymphoblastic Leukemia$412,685
R21 · FY2024 · CA · contact PI
Mechanisms of KLF4 suppression in pediatric leukemia$370,641
R01 · FY2021 · CA · contact PI
Mechanisms of KLF4 suppression in pediatric leukemia$370,641
R01 · FY2020 · CA · contact PI
Mechanisms of KLF4 suppression in pediatric leukemia$359,522
R01 · FY2019 · CA · contact PI
Mechanisms of KLF4 suppression in pediatric leukemia$370,641
R01 · FY2018 · CA · contact PI
Mechanisms of KLF4 suppression in pediatric leukemia$326,540
R01 · FY2017 · CA · contact PI
Transcriptional Regulation of Development and Maintenance of Memory T Lymphocytes$376,113
R01 · FY2011 · AI · contact PI
Transcriptional Regulation of Development and Maintenance of Memory T Lymphocytes$379,913
R01 · FY2010 · AI · contact PI
Transcriptional Regulation of Development and Maintenance of Memory T Lymphocytes$132,730
R01 · FY2010 · AI · contact PI
Transcriptional Regulation of Development and Maintenance of Memory T Lymphocytes$383,750
R01 · FY2009 · AI · contact PI
Transcriptional Regulation of Development and Maintenance of Memory T Lymphocytes$383,750
R01 · FY2008 · AI · contact PI
Regulation of Innate Immunity and Hematopoiesis by MEF$155,979
K01 · FY2007 · CA · contact PI
Regulation of Innate Immunity and Hematopoiesis by MEF$155,979
K01 · FY2006 · CA · contact PI
Regulation of Innate Immunity and Hematopoiesis by MEF$155,979
K01 · FY2005 · CA
Regulation of Innate Immunity and Hematopoiesis by MEF$134,379
K01 · FY2004 · CA
Regulation of Innate Immunity and Hematopoiesis by MEF$133,659
K01 · FY2003 · CA